Filing Details
- Accession Number:
- 0000899243-22-021612
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-09 16:05:11
- Reporting Period:
- 2022-06-07
- Accepted Time:
- 2022-06-09 16:05:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1274792 | Merrimack Pharmaceuticals Inc | MACK | () | UT |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1094201 | L Gary Crocker | C/O Merrimack Pharmaceuticals, Inc. One Broadway 14Th Floor Cambridge MA 02142 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-06-07 | 300 | $5.05 | 126,304 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2022-06-08 | 349 | $5.14 | 126,653 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Footnotes
- Shares held by Crocker Family Investments, LLC, over which Reporting Person is the Managing Member
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.10 to $5.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.